Spearhead Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,996
| Closed | -$438K | – | 227 |
|
|
2021
Q4 | $438K | Buy |
1,996
+15
| +0.8% | +$3.29K | 0.05% | 107 |
|
|
2021
Q3 | $359K | Buy |
1,981
+2
| +0.1% | +$362 | 0.05% | 134 |
|
|
2021
Q2 | $399K | Buy |
1,979
+248
| +14% | +$50K | 0.05% | 142 |
|
|
2021
Q1 | $372K | Buy |
1,731
+743
| +75% | +$160K | 0.05% | 108 |
|
|
2020
Q4 | $234K | Buy |
988
+53
| +6% | +$12.6K | 0.04% | 163 |
|
|
2020
Q3 | $254K | Buy |
935
+66
| +8% | +$17.9K | 0.05% | 153 |
|
|
2020
Q2 | $252K | Buy |
+869
| New | +$252K | 0.05% | 128 |
|